![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 34, 31909-31917, August 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

**
From the
Department of Immunology, University of
Toronto, Sunnybrook and Women's Health Sciences Centre, Toronto, Ontario M4N
3M5, Canada and the ¶Cancer Research Laboratory,
Department of Molecular and Cell Biology, University of California, Berkeley,
California 94720-3200
Mouse NKR-P1C (NK1.1) is a homodimeric type II transmembrane protein
expressed on natural killer (NK) cells, NKT cells, and on CD117+
progenitor thymocytes capable of giving rise to cells of the T and NK
lineages. Although its physiological ligands remain unknown, NKR-P1C
engagement with a monoclonal antibody (mAb) leads to interferon-
(IFN-
) production and the directed release of cytotoxic granules from
NK cells. We have cloned and sequenced a
10-kb genomic fragment
corresponding to the 5'-flanking region of the C57Bl/6 mouse
NKR-P1C gene. A transcriptional initiation site has been mapped in NK
cells and an NK1.1+ T cell line by primer extension and rapid
amplification of 5'-cDNA ends (5'-RACE) techniques. Although the
5'-flanking region of NKR-P1C is TATA-less, we have identified
an initiator region and a downstream promoter element, which together
constitute the principal minimal functional promoter. Computational analysis
of the 10-kb 5'-flanking region revealed potential regulatory factor
binding sites. DNaseI hypersensitivity assays identified a single
hypersensitive site (HS) about a 9-kb upstream of the transcriptional
initiation site. This site, termed HS1, was able to act as a transcriptional
enhancer element in an NK cell line, while minimally affecting transcription
in non-NK cell lines. Moreover, the HS1 element was shown to function as a
promoter, with a transcript detected only in fetal NK1.1+ cells. An
additional promoter and two non-coding exons were also characterized. These
results identify the minimal upstream cis-acting elements, and point
to a complex regulatory mechanism involved in the lineage-specific control of
NKR-P1C expression in NK lymphocytes.
Received for publication, December 18, 2002 , and in revised form, June 10, 2003.
* This work was supported by funds from the Canadian Institute for Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by an Ontario Graduate Scholarship Award.
|| Supported by a Long Term Fellowship from the Human Frontier Science Program.
** Supported by an Investigator Award from the CIHR. To whom correspondence should be addressed: Dept. of Immunology, University of Toronto, Sunnybrook and Women's Health Sciences Centre, Room A-331, 2075 Bayview Ave., Toronto, Ontario M4N 3M5, Canada. Tel.: 416-480-6112; Fax: 416-480-4375; E-mail: jc.zuniga.pflucker{at}utoronto.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. R. Carlyle, A. Mesci, B. Ljutic, S. Belanger, L.-H. Tai, E. Rousselle, A. D. Troke, M.-F. Proteau, and A. P. Makrigiannis Molecular and Genetic Basis for Strain-Dependent NK1.1 Alloreactivity of Mouse NK Cells. J. Immunol., June 15, 2006; 176(12): 7511 - 7524. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Wilhelm, J.-R. Landry, F. Takei, and D. L. Mager Transcriptional Control of Murine CD94 Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types J. Immunol., October 15, 2003; 171(8): 4219 - 4226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |